← All organizations

Takara Bio Inc.

For profitWebsite ↗

Also known as: Takara Bio Inc. | TAKARA BIOTECHNOLOGY(DALIAN)CO.,LTD.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2025

Timeline

1920s

Jun 1, 1925
Takara Bio Inc.— Founded

2000s

Jul 1, 2005
Clontech— Acquired

2010s

May 13, 2016
WaferGen Biosystems— Acquired

Drugs by trial phase (21 distinct, 15 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (10 own, 0 via acquisition)

Phase 1 (8 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (16)

NCT07174427Lead sponsorPhase 3Nov 30, 2025
NCT05963217CollaboratorPhase 1Jul 26, 2023
NCT03259425CollaboratorPhase 2Dec 21, 2017
NCT03252808Lead sponsorPhase 1Sep 25, 2017
NCT03250325Lead sponsorPhase 1/Phase 2Sep 20, 2017
NCT03250325Study directorPhase 1/Phase 2Sep 20, 2017
NCT03155191Lead sponsorPhase 1/Phase 2Jun 1, 2017
NCT03153085Lead sponsorPhase 2May 25, 2017
NCT02869217CollaboratorPhase 1Sep 1, 2016
NCT02428036Lead sponsorPhase 1Jun 1, 2015
NCT02418598CollaboratorPhase 1/Phase 2Apr 1, 2015
NCT02366546CollaboratorPhase 1Mar 1, 2015
NCT02272855Lead sponsorPhase 2Oct 1, 2014
NCT02134262CollaboratorPhase 1/Phase 2May 1, 2014
NCT02096614CollaboratorPhase 1Apr 1, 2014

Details

Founded: Kusatsu, JP Jun 1, 1925
Last known activity: Nov 30, 2025